The FDA’s approval of the first long-acting HIV drug combination yesterday promises to boost the quality of life for people under treatment—trading 3 daily pills for a monthly round of 2 injections, the

A double-blind trial of 160 patients in Argentina offered promising results for convalescent plasma as a COVID-19 treatment,

“It’s the best early birthday present I could wish for…”  

WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way.   Pros: Faster results than conventional vaccine field trials…

The UK vaulted over the US today in the race to immunize citizens against COVID-19 after it became the first Western country to approve the Pfizer/BioNTech vaccine under emergency authorization.

Following Pfizer's news that its COVID-19 vaccine shows 90% efficacy, Russia rushed to report that its Sputnik V vaccine candidate shows 92% efficacy, 

The dominant origin story of Alzheimer’s focuses on the build-up of amyloid protein “clumps” on the brain.  

Psilocybin, the active ingredient in magic mushrooms, worked better than standard antidepressants in treating major depressive disorder in a rigorous 

What does the outcome of the US presidential election mean for science and health? A lot.    The result will not only dictate the future of the nation’s COVID-19 response, but the future of various federal agencies, top officials, health care laws, and global health in…

Remdesivir has recently received 2 huge votes of confidence: a deal to supply the EU with the antiviral, and FDA approval as a COVID-19 treatment.   Both decisions have “baffled” scientists.   The largest remdesivir study so far, from the WHO, showed the…